Arriving at the diagnosis of female sexual dysfunction

Latif, Erin Z.; Diamond, Michael P.

doi:10.1016/j.fertnstert.2013.08.006

Cited by 114 publications

(72 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Validated self-reported measures and structured interviews are recommended as primary end points to evaluate sexual dysfunction interventions [3]. Although all studies in this review stated to have used validated tools or some aspects of them, none of them clearly defined and assessed sexual dysfunction as recommended, including validated measures of distress [3,48], and classified sexual disorders according to an international consensus [49,50]. Therefore, uncertainty remains regarding the amount of sexual dysfunction in each cohort and its influence on results.…”

Section: Discussionmentioning

confidence: 99%

Does pelvic floor muscle training improve female sexual function? A systematic review

Ferreira

Dwyer

Davidson³

et al. 2015

Int Urogynecol J

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Does pelvic floor muscle training improve female sexual function? A systematic review

Ferreira

Dwyer

Davidson³

et al. 2015

Int Urogynecol J

View full text Add to dashboard Cite

show abstract

“…153,154 The classification system for female sexual dysfunction has evolved from a linear categorization of sexual desire, arousal, orgasm and pain disorders (as initially defined by Masters and Johnson) to a more complex and circular model that includes emotional and relational factors. 155 According to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV, there are four categories of sexual dysfunction disorders: sexual desire, arousal, orgasm and sexual pain. In addition, the sexual dysfunction must cause marked distress and personal difficulty in order to be defined as a disorder.…”

Section: Coital Incontinencementioning

confidence: 99%

“…The DSM-5, published in 2013, suggests some changes to the definition of sexual dysfunction; sexual desire and arousal disorders have been combined into one condition-female sexual interest/arousal disorder. 155 The diagnoses of vaginismus and dyspareunia have been merged into a new genitopelvic pain/penetration disorder. The DSM-5 also suggests the differentiation between transient and persistent sexual dysfunction, the latter lasting for ≥6 months with specific severity criteria.…”

Section: Coital Incontinencementioning

confidence: 99%

Stress urinary incontinence and LUTS in women—effects on sexual function

2014

View full text Add to dashboard Cite

The sexual impact of urinary incontinence in women depends on a host of parameters, including physical, psychological, social and cultural dimensions. Evaluation of the effects of stress urinary incontinence (SUI) and lower urinary tract symptoms on sexual function is often biased by their common association with other pelvic floor disorders, such as pelvic organ prolapse, which also affect sexual satisfaction. Indeed, these complexities are reflected in the literature, which shows considerable disparity in sexual functional characteristics in women with incontinence both before and after treatment. This discordance is further emphasized by heterogeneity in study design, quality and analysis. Here, we describe the nature of sexual dysfunction in women with incontinence, including coital incontinence. The various treatments for SUI, which include transvaginal tape surgeries, can also affect sexual function, positively or negatively. Coital incontinence seems to be a good predictor of an improvement in postoperative sexual parameters: its cure, achieved by >90% of women, to a large extent explains the sexual benefits reported in several studies. By contrast, deterioration in sexual function is sometimes reported after surgery, with de novo or worsened dyspareunia being the most common cause. The literature does not contain any convincing arguments for one treatment or another on the basis of sexual functional outcome.

show abstract

“…Sexual dysfunction has been identified in up to 40% of women 1,2 with hypoactive sexual desire representing at least a quarter of these women 3–5 . Acknowledging that there has been controversy regarding the definition and diagnosis of hypoactive sexual desire in women, hypoandrogenism 6–9 has been identified as an etiology of hypoactive sexual desire, consistent with the obligatory role of testosterone to increase libido, frequency of and satisfaction with sexual activity, and orgasm in men.…”

Section: Introductionmentioning

confidence: 99%

Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility

Diamond

Legro

Coutifaris

et al. 2017

American Journal of Obstetrics and Gynecology

Self Cite

View full text Add to dashboard Cite

Background While female sexual dysfunction is a frequent occurrence, characteristics in infertile women are not well delineated. Furthermore, the impact of infertility etiology on the characteristics in women with differing androgen levels observed in women with polycystic ovary syndrome and unexplained infertility has not been assessed. Objective To determine the characteristics of sexual dysfunction in women with polycystic ovary syndrome and unexplained infertility. Study Design Secondary data analysis was performed on two of Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Networks clinical trials, “Pregnancy in Polycystic Ovary Syndrome Study II” and “Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation.” Both protocols assessed female sexual function using the Female Sexual Function Inventory and the Female Sexual Distress Scale. Results Women with polycystic ovary syndrome had higher weight and body mass index than women with unexplained infertility (each p<0.001), greater phenotypic (Ferriman-Gallwey Hirsutism score, sebum score, and acne score; each p<0.001), and hormonal (testosterone, free testosterone, and dehydroepiandrosterone; each p<0.001) evidence of androgen excess. Sexual function scores, as assessed by the Female Sexual Function Inventory were nearly identical. The Female Sexual Distress Scale total score was higher in women with polycystic ovary syndrome. The mean Female Sexual Function Inventory total score increased slightly as the free androgen index increased, mainly as a result of the desire subscore. This association was more pronounced in the women with unexplained infertility. Conclusion Reproductive age women with infertility associated with polycystic ovary syndrome and unexplained infertility, despite phenotypic and biochemical differences in androgenic manifestations, do not manifest clinically significant differences in sexual function.

show abstract

Arriving at the diagnosis of female sexual dysfunction

Cited by 114 publications

References 23 publications

Does pelvic floor muscle training improve female sexual function? A systematic review

Does pelvic floor muscle training improve female sexual function? A systematic review

Stress urinary incontinence and LUTS in women—effects on sexual function

Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility

Contact Info

Product

Resources

About